White House weighs alternatives as Trump FDA nominee Heidi Overton lacks committee votes

Trump FDA nominee Heidi Overton struggling to win enough GOP support to be confirmed

cbsnews.com· · 4d
Open

A CBS News report says President Trump's FDA commissioner nominee Heidi Overton is struggling to find enough Republican support on the Senate Health, Education, Labor and Pensions Committee ahead of its Wednesday vote, and could be pulled if she cannot muster it. The nomination has run aground over her testimony on mifepristone, the abortion drug used in more than half of U.S. abortions and the subject of a safety study she sidestepped questions on, and her handling of Trump's pro-vaping policies. Skeptics include Sen. Josh Hawley, undecided Republicans Susan Collins and Lisa Murkowski, the Susan B. Anthony group, and former MAHA leader Calley Means, while sources say the White House has begun looking at other candidates, including some who could serve in an acting capacity and skip Senate confirmation, with Sen. Roger Marshall making a play for the post. Committee chairman Sen. Bill Cassidy said he was still uncertain how the vote would go and questioned whether a series of short-term acting administrators would have less independence than a permanent one.

Senate health chair unsure if Trump’s FDA pick has support to pass committee’s vote

washingtonpost.com· · 6d
Open

A Washington Post live blog leads with Sen. Bill Cassidy, the Senate health committee chair, saying he is not sure whether President Trump's pick to lead the FDA, Heidi Overton, has the support to pass the committee's vote, scheduled for Wednesday. Cassidy says he still has questions about Overton's suitability and her support for Trump's August executive order reducing recommended childhood vaccines, which he has said should be almost disqualifying. Overton, a White House Domestic Policy Council aide, has praised that order as historic, though at her September hearing she called the combined measles, mumps and rubella vaccine safe and effective, pushing back on Trump's characterization of it as quite lethal. Cassidy says his choice is between backing a nominee he has reservations about or voting no and leaving the FDA position unfilled as Democrats take control of Congress next year.

Bill Cassidy says Trump’s FDA pick faces uncertain committee vote

politico.com· · 6d
Open

Senate HELP Committee Chair Bill Cassidy says he still has questions about President Trump's FDA nominee Heidi Overton, leaving the committee's vote set for 18 November 2026 uncertain as Republicans race to confirm nominees before Democrats take control of the Senate in January 2027. Cassidy, wrapping up his 12-year Senate career after losing his party's primary, says he has been working the phones with Overton and fellow Republican members and cannot tell the outcome. The questions go beyond vaccines: at her September confirmation hearing Overton pushed back on Trump's false claim that the measles, mumps and rubella vaccine is lethal, calling it safe and effective, but Republican Sens. Susan Collins and Lisa Murkowski have raised concerns about flavored vapes, political pressure on scientific reviews, and the abortion drug mifepristone.

Sign in with subscription

Free during the beta.

Clear all notifications?

Your bells stay on. Only this list empties.